BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 24686772)

  • 1. Prostate cancer diagnosis through electronic nose in the urine headspace setting: a pilot study.
    Asimakopoulos AD; Del Fabbro D; Miano R; Santonico M; Capuano R; Pennazza G; D'Amico A; Finazzi-Agrò E
    Prostate Cancer Prostatic Dis; 2014 Jun; 17(2):206-11. PubMed ID: 24686772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of prostate cancer by an electronic nose: a proof of principle study.
    Roine A; Veskimäe E; Tuokko A; Kumpulainen P; Koskimäki J; Keinänen TA; Häkkinen MR; Vepsäläinen J; Paavonen T; Lekkala J; Lehtimäki T; Tammela TL; Oksala NK
    J Urol; 2014 Jul; 192(1):230-4. PubMed ID: 24582536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olfactory detection of prostate cancer by dogs sniffing urine: a step forward in early diagnosis.
    Cornu JN; Cancel-Tassin G; Ondet V; Girardet C; Cussenot O
    Eur Urol; 2011 Feb; 59(2):197-201. PubMed ID: 20970246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VOC-based detection of prostate cancer using an electronic nose and ion mobility spectrometry: A novel urine-based approach.
    Heers H; Chwilka O; Huber J; Vogelmeier C; Koczulla AR; Baumbach JI; Boeselt T
    Prostate; 2024 Jun; 84(8):756-762. PubMed ID: 38497426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of a new electronic nose for prostate cancer diagnosis in urine samples.
    Taverna G; Grizzi F; Tidu L; Bax C; Zanoni M; Vota P; Lotesoriere BJ; Prudenza S; Magagnin L; Langfelder G; Buffi N; Casale P; Capelli L
    Int J Urol; 2022 Aug; 29(8):890-896. PubMed ID: 35534435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transperineal prostate biopsy detects significant cancer in patients with elevated prostate-specific antigen (PSA) levels and previous negative transrectal biopsies.
    Dimmen M; Vlatkovic L; Hole KH; Nesland JM; Brennhovd B; Axcrona K
    BJU Int; 2012 Jul; 110(2 Pt 2):E69-75. PubMed ID: 22093091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High concordance of gene methylation in post-digital rectal examination and post-biopsy urine samples for prostate cancer detection.
    Rogers CG; Gonzalgo ML; Yan G; Bastian PJ; Chan DY; Nelson WG; Pavlovich CP
    J Urol; 2006 Nov; 176(5):2280-4. PubMed ID: 17070312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olfactory system of highly trained dogs detects prostate cancer in urine samples.
    Taverna G; Tidu L; Grizzi F; Torri V; Mandressi A; Sardella P; La Torre G; Cocciolone G; Seveso M; Giusti G; Hurle R; Santoro A; Graziotti P
    J Urol; 2015 Apr; 193(4):1382-7. PubMed ID: 25264338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PCA3 molecular urine test as a predictor of repeat prostate biopsy outcome in men with previous negative biopsies: a prospective multicenter clinical study.
    Gittelman MC; Hertzman B; Bailen J; Williams T; Koziol I; Henderson RJ; Efros M; Bidair M; Ward JF
    J Urol; 2013 Jul; 190(1):64-9. PubMed ID: 23416644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A three-gene panel on urine increases PSA specificity in the detection of prostate cancer.
    Rigau M; Ortega I; Mir MC; Ballesteros C; Garcia M; Llauradó M; Colás E; Pedrola N; Montes M; Sequeiros T; Ertekin T; Majem B; Planas J; Ruiz A; Abal M; Sánchez A; Morote J; Reventós J; Doll A
    Prostate; 2011 Dec; 71(16):1736-45. PubMed ID: 21520154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential benefit of transrectal saturation prostate biopsy as an initial biopsy strategy: decreased likelihood of finding significant cancer on future biopsy.
    Li YH; Elshafei A; Li J; Hatem A; Zippe CD; Fareed K; Jones JS
    Urology; 2014 Apr; 83(4):714-8. PubMed ID: 24680442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular PCA3 diagnostics on prostatic fluid.
    van Gils MP; Cornel EB; Hessels D; Peelen WP; Witjes JA; Mulders PF; Rittenhouse HG; Schalken JA
    Prostate; 2007 Jun; 67(8):881-7. PubMed ID: 17440939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of telomerase activity for the detection of prostatic cancer cells after prostatic massage.
    Meid FH; Gygi CM; Leisinger HJ; Bosman FT; Benhattar J
    J Urol; 2001 May; 165(5):1802-5. PubMed ID: 11342979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer detection by GSTP1 methylation analysis of postbiopsy urine specimens.
    Gonzalgo ML; Pavlovich CP; Lee SM; Nelson WG
    Clin Cancer Res; 2003 Jul; 9(7):2673-7. PubMed ID: 12855646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High diagnostic ability of multiparametric magnetic resonance imaging to detect anterior prostate cancer missed by transrectal 12-core biopsy.
    Komai Y; Numao N; Yoshida S; Matsuoka Y; Nakanishi Y; Ishii C; Koga F; Saito K; Masuda H; Fujii Y; Kawakami S; Kihara K
    J Urol; 2013 Sep; 190(3):867-73. PubMed ID: 23542406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation biomarkers of prostate cancer: confirmation of candidates and evidence urine is the most sensitive body fluid for non-invasive detection.
    Payne SR; Serth J; Schostak M; Kamradt J; Strauss A; Thelen P; Model F; Day JK; Liebenberg V; Morotti A; Yamamura S; Lograsso J; Sledziewski A; Semjonow A
    Prostate; 2009 Sep; 69(12):1257-69. PubMed ID: 19459176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High detection rate of significant prostate tumours in anterior zones using transperineal ultrasound-guided template saturation biopsy.
    Mabjeesh NJ; Lidawi G; Chen J; German L; Matzkin H
    BJU Int; 2012 Oct; 110(7):993-7. PubMed ID: 22394668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and pathological features of prostate cancer detected on transperineal template guided mapping biopsy after negative transrectal ultrasound guided biopsy.
    Bittner N; Merrick GS; Butler WM; Bennett A; Galbreath RW
    J Urol; 2013 Aug; 190(2):509-14. PubMed ID: 23416641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transperineal template-guided prostate biopsy for patients with persistently elevated PSA and multiple prior negative biopsies.
    Gershman B; Zietman AL; Feldman AS; McDougal WS
    Urol Oncol; 2013 Oct; 31(7):1093-7. PubMed ID: 22305626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Differentiation of prostate cancer from benign prostatic disease by total prostate specific antigen dynamic profiles after transrectal prostate biopsy].
    Shao Q; Song J; Zhou ZJ; Du LD
    Zhonghua Nan Ke Xue; 2008 Jul; 14(7):597-601. PubMed ID: 18686378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.